Skip to main content

GE Healthcare Inc. Life Sciences

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20181
Download CSV

FDA Recall Terminated Historical recordClass II

Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.

by GE Healthcare Inc. Life Sciences

Reason
Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.
Published
December 26, 2018
Distribution
TN

View recall →

Showing 1–1 of 1 results

This page lists recalls that name GE Healthcare Inc. Life Sciences as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.